Ex Parte MattieDownload PDFPatent Trial and Appeal BoardJun 24, 201413030996 (P.T.A.B. Jun. 24, 2014) Copy Citation UNITED STATES PATENT AND TRADEMARK OFFICE ____________ BEFORE THE PATENT TRIAL AND APPEAL BOARD ____________ Ex parte DAVID MATTIE ____________ Appeal 2012-012557 Application 13/030,996 Technology Center 1700 ____________ Before CHARLES F. WARREN, BEVERLY A. FRANKLIN, and CHRISTOPHER M. KAISER, Administrative Patent Judges. KAISER, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35 U.S.C. § 134 from the decision of the Primary Examiner finally rejecting claims 1-16. We have jurisdiction under 35 U.S.C. § 6(b). We affirm. OPINION Appellant’s invention is directed to “formulations for frozen slush drinks containing . . . plant extracts.” Spec. 1, ll. 8-9. Claim 1, reproduced below, is representative of the appealed subject matter: 1) A frozen slush drink consisting of: Appeal 2012-012557 Application 13/030,996 2 a) water, b) at least one sugar selected from glucose, sucrose, fructose, maltose and other naturally occurring higher molecular weight sugars, c) tea plant extract flavoring, d) carboxymethylcellulose, and, e) xanthan gum, guar gum and locust bean gum. Claims App., Appeal Br. 17. At the time of the Final Rejection, claims 1-16 were pending. Final Rej. 1. The Examiner rejected claims 1-6 and 9-14 under 35 U.S.C. § 103(a) as obvious over both the combination of Dunn,1 Nayyar,2 Mihajlovic,3 Syfert,4 Igoe,5 and Wang6 and the combination of Dunn, Nayyar, Mihajlovic, Syfert, Igoe, and Fukuoka.7 Final Rej. 2-16. The Examiner also rejected claims 7, 8, 15, and 16 under 35 U.S.C. § 103(a) as obvious over both the combination of Dunn, Nayyar, Mihajlovic, Syfert, Igoe, Wang, and Arbuckle8 and the combination of Dunn, Nayyar, Mihajlovic, Syfert, Igoe, Fukuoka, and Arbuckle. Id. at 17-33. We sustain each of the above rejections based on the findings of fact, conclusions of law, and rebuttals to arguments which are well expressed by the Examiner in the Final Rejection, the Advisory Action, and the Answer. The following comments are added for emphasis. 1 Dunn, US 3,073,703, issued Jan. 15, 1963. 2 Nayyar et al., US 5,853,785, issued Dec. 29, 1998. 3 Mihajlovic, US 2003/0215548 A1, published Nov. 20, 2003. 4 Syfert et al., US 4,748,033, issued May 31, 1988. 5 ROBERT S. IGOE & Y.H. HUI, DICTIONARY OF FOOD INGREDIENTS 69-72, 84, 154 (3d ed. 1996). 6 Wang, CN 1108895 A, published Sept. 27, 1995. 7 Fukuoka, JP 62257344 A, published Nov. 9, 1987. 8 Arbuckle, US 3,479,187, issued Nov. 18, 1969. Appeal 2012-012557 Application 13/030,996 3 Appellant argues that the particular combination of ingredients claimed produces the unexpected and surprising “result of a stable tea flavored frozen slush drink.” Appeal Br. 9. Appellant notes that “leaving out any single ingredient made an unacceptable product” and that “[t]here is nothing in the reference[s] cited that would have rendered this result predictable.” Id. For the reasons provided in the Answer, we agree with the Examiner that there is insufficient evidence to show that the claimed invention produces unexpected results over the prior art. Ans. 4-5. In addition, we note that, even to the extent that the experimental results reported in Appellant’s Specification, Spec. 8-11, show that the claimed invention is an improvement over the prior art, there is no evidence as to what improvement a person of ordinary skill in the art would have expected from the claimed combination of ingredients or what additional improvement beyond an expected result was demonstrated by the claimed invention. See Pfizer, Inc. v. Apotex, Inc., 480 F.3d 1348, 1371 (Fed. Cir. 2007) (“any superior property must be unexpected to be considered as evidence of non-obviousness”). Appellant’s arguments that the experimental results were unexpected and surprising are not a substitute for such evidence. In re Geisler, 116 F.3d 1465, 1470 (Fed. Cir. 1997). The decision of the Examiner is affirmed. No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136. AFFIRMED cdc Copy with citationCopy as parenthetical citation